Oleanolic Acid: A Novel Cardioprotective Agent That Blunts Hyperglycemia-Induced Contractile Dysfunction

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mapanga, Rudo F ^a   Rajamani, Uthra ^a   Dlamini, Nonkululeko ^b   Zungu Edmondson, Makhosazane ^b   Kelly Laubscher, Roisin ^c   Shafiullah, Mohammed ^d   Wahab, Athiq ^d   Hasan, Mohamed Y ^d   Fahim, Mohamed A ^d   Rondeau, Philippe ^e   Bourdon, Emmanuel ^e   Essop, M Faadiel ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^e UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEXOSAMINE; OLEANOLIC ACID; PROTEASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTRACTILE DYSFUNCTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; EX VIVO STUDY; HEART DISEASE; HEART FUNCTION; HEART PROTECTION; HYPERGLYCEMIA; IN VIVO STUDY; ISOLATED HEART; LONG TERM CARE; MALE; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; EUGENIA; HEART; HYPERGLYCEMIA; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OLEANOLIC ACID; PLANT EXTRACTS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; REACTIVE OXYGEN SPECIES;

EID: 84867593313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047322     Document Type: Article

References (63)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Bradshaw D, Norman R, Pieterse D, Levitt NS, (2007) Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J 97: 700-706.
3. Mazonne T, Chait A, Plutzky J, (2008) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371: 1800-1809.
4. Boudina S, Abel ED, (2007) Diabetic cardiomyopathy revisited. Circulation 115: 3213-23.
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D, (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444.
6. Capes SE, Hunt D, Malmberg K, Gerstein HC, (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355: 773-778.
7. Marfella R, Di Filippo C, Portoghese M, Ferraraccio F, Rizzo MR, et al. (2009) Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 53: 1425-1436.
8. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS, (1986) Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 293: 917-922.
9. Ceriello A, (2000) Oxidative stress and glycemic regulation. Metabolism 49: 27-29.
10. Marfella R, Di Filippo C, Poroghese M, Siniscalchi M, Martis S, et al. (2009) The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol 18: 332-345.
11. Gokhroo R, Mittal SR, (1989) Electrocardiographic correlates of hyperglycemia in acute myocardial infarction. Int J Cardiol 22: 267-9.
12. Cai L, Li W, Wang G, Guo L, Jiang Y, et al. (2002) Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51: 1938-1948.
13. Rajamani U, Essop MF, (2010) Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299: C139-147.
14. Rajamani U, Joseph D, Roux S, Essop MF, (2011) The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insulin resistance. Acta Physiol 202: 151-157.
15. Powell SR, Samuel SM, Wang P, Divald A, Thirunavukkarasu M, et al. (2008) Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia. J Mol Cell Cardiol 44: 618-621.
16. Pye J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, et al. (2003) Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 284: H919-926.
17. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, et al. (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276: 30057-30063.
18. Gurib-Fakem A, (2006) Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27: 1-93.
19. Liu J, (1995) Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 49: 57-68.
20. Senthil S, Sridevi M, Pugalendi KV, (2007) Cardioprotective effect of oleanolic acid on isoproterenol-induced myocardial ischemia in rats. Toxicol Pathol 35: 418-423.
21. Mapanga RF, Tufts MA, Shode FO, Musabayane CT, (2009) Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats. Renal Fail 31: 481-491.
22. Du Y, Ko KM, (2006) Effects of pharmacological preconditioning by emodin/oleanolic acid treatment and/or ischemic preconditioning on mitochondrial antioxidant components as well as the susceptibility to ischemia-reperfusion injury in rat hearts. Mol Cell Biochem 288: 135-142.
23. Somova LI, Shode FO, Ramnanan P, Nadar A, (2003) Antihypertensive, antiathersoclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J Ethnopharmacol 84: 299-305.
24. Hostettmann K, Marston A (1995) Chemistry and Pharmacology of Natural Products: Saponins. Cambridge University Press, UK.
25. Musabayane CT, Tufts MA, Mapanga RF, (2010) Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin-induced diabetic rats. Renal Fail 32: 832-839.
26. Ge F, Zeng F, Liu S, Guo N, Ye H, et al. (2010) In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis. J Med Microbiol 59: 567-572.
27. Kelly RF, Lamont KT, Somers S, Hacking D, Lacerda L, et al. (2010) Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res Cardiol 105: 763-770.
28. Walker WJ, Mundall SL, Broderick HG, Prasad B, Kim J, et al. (1973) Systemic heparinization for femoral percutaneous coronary arteriography. New Eng J Med 288: 826-828.
29. Eyer KM, (1973) Complications of transfemoral coronary arteriography and their prevention using heparin. Am Heart J 86: 428.
30. Deuchar GA, Opie LH, Lecour S, (2007) TNFalpha is required to confer protection in an in vivo model of classical ischemic preconditioning. Life Sci 80: 1686-1691.
31. Howarth FC, Qureshi MA, (2001) Characterisation of ventricular myocyte shortening after administration of streptozotocin (STZ) to neonatal rats. Arch Physiol Biochem 109: 200-205.
32. Kaiserova K, Srivastava S, Hoetker JD, Awe SO, Tang XL, et al. (2006) Redox activation of aldose reductase in the ischemic heart. J Biol Chem 281: 15110-15120.
33. Requena JR, Levine RL, Stadtman ER, (2003) Recent advances in the analysis of oxidized proteins. Amino Acids 25: 221-226.
34. Friguet B, Bulteau AL, Conconi M, Petropulos I, (2002) Redox control of 20S proteasome. Methods Enzymol 353: 253-262.
35. Choi CY, You HJ, Jeong HG, (2001) Nitric oxide and tumor necrosis factor-α production by oleanolic acid via nuclear factor-κβ activation in macrophages. Biochem Biophys Res Commun 288: 49-55.
36. Ali MS, Jahangir M, Hussan SS, Choudhary MI, (2002) Inhibition of α-glucosidase by oleanolic acid and its synthetic derivatives. Phytochemistry 60: 295-299.
37. Han SK, Ko YI, Park SJ, Jin IJ, Kim YM, (1997) Oleanolic acid and ursolic acid stabilize liposomal membranes. Lipids 32: 769-773.
38. Du Y, Ko KM, (2006) Oleanolic acid protects against myocardial ischemia-reperfusion injury by enhancing mitochondrial antioxidant mechanism mediated by glutathione and alpha-tocopherol in rats. Planta Med 72: 222-227.
39. Wang X, Ye XL, Liu R, Chen HL, Bai H, et al. (2010) Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem Biol Interact 184: 328-337.
40. Soobrattee MA. Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T, (2005) Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutant Res 579: 200-213.
41. Rong ZT, Gong XJ, Sun HB, Li YM, Ji H, (2011) Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H2O2-induced injury in vitro. Pharm Biol 49: 78-85.
42. Wang X, Li YL, Wu H, Liu JZ, Hu,JX, et al, (2011) Antidiabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent. Phytotherapy Res 25: 1031-1040.
43. Jaiswal AK, (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36: 1199-1207.
44. Kensler TW, Wakabayashi N, Biswal S, (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116.
45. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, et al. (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 46: 443-53.
46. Ichikawa T, Li J, Meyer CJ, Janicki JS, Hannink M, et al. (2009) Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes. PLoS ONE 4(12): e8391 doi:10.1371/journal.pone.0008391.
47. Ceriello A, Quagliaro L, D'Amico M, Filippo C, Margella R, et al. (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51: 1076-1082.
48. Brown GC, (2001) Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504: 46-57.
49. Xie YW, Wolin MS, (1996) Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation 94: 2580-2586.
50. Arstall MA, Sawyer DB, Fukazawa R, Kelly RA, (1999) Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85: 829-840.
51. Tang WH, Cheng WT, Kravtsov GM, Tong XY, Hou XY, et al. (2010) Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Am J Physiol Cell Physiol 299: C643-C653.
52. D'Amico M, Marfella R, Nappo F, Di Filippo C, De Angelis L, et al. (2001) High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia 44: 464-470.
53. Di Filippo C, Cuzzocrea S, Marfella R, Fabbroni V, Scollo G, et al. (2004) M40403 prevents myocardial injury by acute hyperglycaemia in perfused rat heart. Eur J Pharmacol 497: 65-74.
54. Yu X, Kem DC, (2010) Proteasome inhibition during myocardial infarction. Cardiovasc Res 85: 312-320.
55. Wang X, Li J, Zheng H, Su H, Powell SR, (2011) Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol 301: H2207-2219.
56. Baldwin AS Jr, (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.
57. Ghosh S, May MJ, Kopp EB, (1998) NF-kappa and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260.
58. Van den Berghe G, (2011) Coronary bypass surgery: protective effects of insulin or of prevention of hyperglycemia, or both? J Clin Endocrinol Metab 96: 1272-1275.
59. Sack MN, Yellon DM, (2001) Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation. J Am Coll Cardiol 41: 1404-1407.
60. Jonassen AK, Sack MN, Mjøs OD, Yellon DM, (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling. Circ Res 89: 1191-1198.
61. Cross HR, Clarke K, Opie LH, Radda GK, (1995) Is lactate-induced myocardial ischemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol 27: 1369-1381.
62. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, et al. (2005) CREATE-ECLA Trial Group investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trail. JAMA 293: 437-446.
63. Carvalho G, Pelletier P, Albacker T, Lachapelle K, Joanisse DR, et al. (2011) Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. J Clin Endcrinol Metab 96: 1469-1477.